Toledano Miranda Jayne
SEC CIK 1686530 · EDGAR
BoughtSold
Most active insiders at ENTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Germano Geno J | Dir | $55.8K | — |
| 2 | Ellis Sean | Dir | $34.6K | — |
| 3 | Toledano Miranda Jayne | CEO, Dir | $19.9K | — |
| 4 | Rubin Steven D | Dir | $19.4K | — |
| 5 | Taitel Haya | Dir | $11.1K | — |
| 6 | Burshtein Gregory | Chief of R, D | — | — |
| 7 | Yaacov-Garbeli Dana | CFO | — | — |
| 8 | Malca Yonatan | Dir | — | — |
| 9 | Galitzer Hillel | COO | — | — |
| 10 | OSTROV GERALD M | Dir | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-07-16 16:05 | 2026-07-14 | ENTX | Entera Bio Ltd. | Toledano Miranda Jayne | CEO, Dir | A - Grant | $0.00 | +420.6K | 847.1K | +99% | $0 |
| 2026-07-02 16:07 | 2026-07-01 | DERM | Journey Medical Corp | Toledano Miranda Jayne | Dir | A - Grant | $0.00 | +50.0K | 168.6K | +42% | $0 | |
| 2026-06-29 16:05 | 2026-06-25 | DERM | Journey Medical Corp | Toledano Miranda Jayne | Dir | A - Grant | $0.00 | +10.0K | 118.6K | +9% | $0 | |
| 2025-12-30 | 2025-12-29 | ENTX | Entera Bio Ltd. | Toledano Miranda Jayne | CEO, Dir | P - Purchase | $1.81 | +11.0K | 426.6K | +3% | +$19.9K | |
| 2025-08-07 | 2025-08-05 | DERM | Journey Medical Corp | Toledano Miranda Jayne | Dir | A - Grant | $0.00 | +20.0K | 108.6K | +23% | $0 | |
| DM | 2025-07-18 | 2025-07-16 | ENTX | Entera Bio Ltd. | Toledano Miranda Jayne | CEO, Dir | A - Grant | $0.00 | +180.7K | 371.7K | +95% | $0 |
| 2025-07-07 | 2025-06-25 | DERM | Journey Medical Corp | Toledano Miranda Jayne | Dir | A - Grant | $0.00 | +7,173 | 88.6K | +9% | $0 | |
| D | 2024-08-02 | 2024-07-31 | ENTX | Entera Bio Ltd. | Toledano Miranda Jayne | CEO, Dir | A - Grant | $0.00 | +124.1K | 234.9K | +112% | $0 |
| 2024-07-10 | 2024-07-08 | DERM | Journey Medical Corp | Toledano Miranda Jayne | Dir | A - Grant | $0.00 | +9,728 | 81.4K | +14% | $0 | |
| D | 2023-12-27 | 2023-12-22 | ENTX | Entera Bio Ltd. | Toledano Miranda Jayne | CEO, Dir | P - Purchase | $0.71 | +24.0K | 110.8K | +28% | +$17.0K |
| 2023-07-25 | 2023-07-21 | DERM | Journey Medical Corp | Toledano Miranda Jayne | Dir | A - Grant | $0.00 | +27.5K | 71.7K | +62% | $0 | |
| 2023-04-06 | 2023-04-04 | ENTX | Entera Bio Ltd. | Toledano Miranda Jayne | CEO, Dir | P - Purchase | $1.01 | +30.0K | 86.8K | +53% | +$30.3K | |
| 2022-11-14 | 2022-11-11 | ENTX | Entera Bio Ltd. | Toledano Miranda Jayne | CEO, Dir | P - Purchase | $0.53 | +50.0K | 56.8K | +735% | +$26.5K | |
| 2022-07-25 | 2022-07-21 | DERM | Journey Medical Corp | Toledano Miranda Jayne | Dir | A - Grant | $0.00 | +14.2K | 44.2K | +47% | $0 | |
| 2022-04-04 | 2022-01-14 | DERM | Journey Medical Corp | Toledano Miranda Jayne | Dir | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 | |
| 2022-01-19 | 2022-01-14 | ENTX | Entera Bio Ltd. | Toledano Miranda Jayne | Dir | P - Purchase | $2.79 | +6,800 | 6,800 | New | +$19.0K | |
| D | 2022-01-03 | 2021-12-27 | NXGL | NEXGEL, INC. | Toledano Miranda Jayne | Dir | P - Purchase | $5.49 | +1,819 | 1,819 | New | +$9,986 |
Purchase Sale Sale after option exercise All abbreviations